SS
PRAX icon

SBI Securities’s Praxis Precision Medicines PRAX Stock Holding History

SBI Securities’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Sell
55
-12
-18% -$3.8K ﹤0.01% 1572
2026
Q1 		$21.6K Sell
67
-7
-9% -$2.17K ﹤0.01% 1431
2025
Q4 		$21.8K Sell
74
-9
-11% -$1.68K ﹤0.01% 1407
2025
Q3 		$4.4K Buy
83
+8
+11% +$388 ﹤0.01% 2097
2025
Q2 		$3.15K Buy
75
+10
+15% +$381 ﹤0.01% 2196
2025
Q1 		$2.46K Buy
65
+5
+8% +$312 ﹤0.01% 2205
2024
Q4 		$4.62K Buy
+60
New +$4.34K ﹤0.01% 1953

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SBI Securities's PRAX Position: Q2 2026 in Review

SBI Securities reduced its Praxis Precision Medicines (PRAX) stake by 18% in Q2 2026, selling an estimated $3.8K and leaving 55 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

SBI Securities first reported a position in PRAX in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.8K in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • SBI Securities held 55 shares of Praxis Precision Medicines worth $18.4K as of Q2 2026.
  • SBI Securities sold 12 Praxis Precision Medicines shares in Q2 2026, an estimated $3.8K.
  • Praxis Precision Medicines made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1572 holding.
  • SBI Securities first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Praxis Precision Medicines position peaked at $21.8K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.